Compare Suven Life Sciences with Sun Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN LIFE SCIENCES vs SUN PHARMA - Comparison Results

SUN PHARMA 
   Change

Sun Pharma holds 3.7% share of the domestic pharma market (as per the latest ORG IMS MAT data) and has a strong presence in the lifestyle therapeutic segments. The company started focusing on the exports market in FY02, when it increased its stake to... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUVEN LIFE SCIENCES SUN PHARMA SUVEN LIFE SCIENCES/
SUN PHARMA
 
P/E (TTM) x -83.0 76.0 - View Chart
P/BV x 1.3 3.2 40.2% View Chart
Dividend Yield % 1.8 0.7 269.0%  

Financials

 SUVEN LIFE SCIENCES   SUN PHARMA
EQUITY SHARE DATA
    SUVEN LIFE SCIENCES
Mar-19
SUN PHARMA
Mar-20
SUVEN LIFE SCIENCES/
SUN PHARMA
5-Yr Chart
Click to enlarge
High Rs338484 69.8%   
Low Rs169315 53.7%   
Sales per share (Unadj.) Rs52.1136.9 38.1%  
Earnings per share (Unadj.) Rs6.817.5 39.1%  
Cash flow per share (Unadj.) Rs8.626.0 33.0%  
Dividends per share (Unadj.) Rs1.504.00 37.5%  
Dividend yield (eoy) %0.61.0 59.1%  
Book value per share (Unadj.) Rs65.3188.7 34.6%  
Shares outstanding (eoy) m127.282,399.26 5.3%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.92.9 166.6%   
Avg P/E ratio x37.122.9 162.1%  
P/CF ratio (eoy) x29.615.4 192.5%  
Price / Book Value ratio x3.92.1 183.3%  
Dividend payout %22.022.9 95.8%   
Avg Mkt Cap Rs m32,272958,864 3.4%   
No. of employees `0001.117.8 6.1%   
Total wages/salary Rs m66163,624 1.0%   
Avg. sales/employee Rs Th6,132.218,490.6 33.2%   
Avg. wages/employee Rs Th611.13,582.6 17.1%   
Avg. net profit/employee Rs Th803.52,357.6 34.1%   
INCOME DATA
Net Sales Rs m6,635328,375 2.0%  
Other income Rs m2426,360 3.8%   
Total revenues Rs m6,877334,735 2.1%   
Gross profit Rs m1,60469,898 2.3%  
Depreciation Rs m22120,528 1.1%   
Interest Rs m383,027 1.2%   
Profit before tax Rs m1,58752,702 3.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-2,606 0.0%   
Tax Rs m7188,228 8.7%   
Profit after tax Rs m86941,868 2.1%  
Gross profit margin %24.221.3 113.6%  
Effective tax rate %45.215.6 289.7%   
Net profit margin %13.112.8 102.8%  
BALANCE SHEET DATA
Current assets Rs m6,232316,542 2.0%   
Current liabilities Rs m1,490157,064 0.9%   
Net working cap to sales %71.548.6 147.2%  
Current ratio x4.22.0 207.5%  
Inventory Days Days8688 98.7%  
Debtors Days Days83105 78.9%  
Net fixed assets Rs m4,043243,102 1.7%   
Share capital Rs m1272,399 5.3%   
"Free" reserves Rs m8,183450,245 1.8%   
Net worth Rs m8,310452,645 1.8%   
Long term debt Rs m1820,289 0.1%   
Total assets Rs m10,389682,525 1.5%  
Interest coverage x43.118.4 234.2%   
Debt to equity ratio x00 4.8%  
Sales to assets ratio x0.60.5 132.7%   
Return on assets %8.76.6 132.7%  
Return on equity %10.59.2 113.1%  
Return on capital %19.511.2 173.7%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m5,62274,219 7.6%   
Fx outflow Rs m1,79927,964 6.4%   
Net fx Rs m3,82246,255 8.3%   
CASH FLOW
From Operations Rs m35665,548 0.5%  
From Investments Rs m-279-25,888 1.1%  
From Financial Activity Rs m-225-57,151 0.4%  
Net Cashflow Rs m-148-13,857 1.1%  

Share Holding

Indian Promoters % 63.4 63.7 99.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 5.1 -  
FIIs % 0.0 23.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 36.5 8.3 439.8%  
Shareholders   37,287 133,026 28.0%  
Pledged promoter(s) holding % 0.0 0.5 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUVEN LIFE SCIENCES With:   ALEMBIC  SHASUN PHARMA  PFIZER  FDC  ORCHID PHARMA  

Compare SUVEN LIFE SCIENCES With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades Over 200 Points Higher; Dow Futures Down by 90 Points(12:30 pm)

Share markets in India are presently trading on a strong note. The BSE Sensex is trading up by 209 points, up 0.4% at 50,058 levels.

Related Views on News

SUN PHARMA Announces Quarterly Results (3QFY21); Net Profit Up 87.4% (Quarterly Result Update)

Feb 1, 2021 | Updated on Feb 1, 2021

For the quarter ended December 2020, SUN PHARMA has posted a net profit of Rs 19 bn (up 87.4% YoY). Sales on the other hand came in at Rs 88 bn (up 8.4% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

SUN PHARMA 2019-20 Annual Report Analysis (Annual Result Update)

Dec 11, 2020 | Updated on Dec 11, 2020

Here's an analysis of the annual report of SUN PHARMA for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of SUN PHARMA. Also includes updates on the valuation of SUN PHARMA.

SUN PHARMA Announces Quarterly Results (2QFY21); Net Profit Up 66.9% (Quarterly Result Update)

Nov 6, 2020 | Updated on Nov 6, 2020

For the quarter ended September 2020, SUN PHARMA has posted a net profit of Rs 19 bn (up 66.9% YoY). Sales on the other hand came in at Rs 86 bn (up 5.3% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

SUN PHARMA Announces Quarterly Results (4QFY20); Net Profit Down 31.6% (Quarterly Result Update)

May 28, 2020 | Updated on May 28, 2020

For the quarter ended March 2020, SUN PHARMA has posted a net profit of Rs 5 bn (down 31.6% YoY). Sales on the other hand came in at Rs 82 bn (up 14.3% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

SUN PHARMA Announces Quarterly Results (3QFY20); Net Profit Down 29.8% (Quarterly Result Update)

Feb 7, 2020 | Updated on Feb 7, 2020

For the quarter ended December 2019, SUN PHARMA has posted a net profit of Rs 10 bn (down 29.8% YoY). Sales on the other hand came in at Rs 82 bn (up 5.4% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

More Views on News

Most Popular

It's the Beginning of a New Bull Phase in Smallcaps(Profit Hunter)

Feb 24, 2021

Last time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.

Make Rs 5,000 Per Day Trading the Market(Fast Profits Daily)

Feb 25, 2021

In this video, I'll show you how to get started on the path to daily trading profits.

I Believe the Investment of the Year Will Be...

Feb 19, 2021

In this episode, ace trader Brijesh Bhatia talks to us about the best investments of 2021, his profitable trading system, and much more.

The Hidden Tesla in My Great Indian Wealth Project(Profit Hunter)

Feb 23, 2021

An Indian company founded three decades ago in a garage caught my attention...

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

SUVEN LIFE SCIENCES SHARE PRICE


Mar 2, 2021 12:44 PM

TRACK SUVEN LIFE SCIENCES

  • Track your investment in SUVEN LIFE SCIENCES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON SUVEN LIFE SCIENCES

SUVEN LIFE SCIENCES 5-YR ANALYSIS

COMPARE SUVEN LIFE SCIENCES WITH

MARKET STATS